FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2766871901> ?p ?o ?g. }

• W2766871901 endingPage "e8176" @default.
• W2766871901 startingPage "e8176" @default.
• W2766871901 abstract "Paclitaxel has been shown to have clinical activity in the treatment of small cell lung cancer (SCLC). However, its role as third-line chemotherapy for SCLC after both etoposide- and camptothecin-based regimens has not been clarified. All patients with refractory SCLC who were treated with paclitaxel-based regimen as third-line chemotherapy between 2005 and 2011 in Seoul National University Bundang Hospital were reviewed retrospectively. Forty patients previously treated with both etoposide- and camptothecin-based chemotherapy were included. The median age of the enrolled patients was 67 years (range, 35–86 years). Most patients (77.5%) received cisplatin plus etoposide as first-line therapy, and camptothecins such as irinotecan or topotecan as second-line therapy. Of 34 patients with measurable lesions, 8 patients (23.5%) achieved partial response and 9 (26.5%) had stable disease. The median progression-free survival (PFS) and overall survival (OS) were 2.5 and 5.9 months, respectively. Predictive factors for OS were performance status (PS) (PS <2 vs ≥2; P = .001), the presence of liver metastasis (P < .001), and number of metastatic sites (<3 vs ≥3; P = .047) in univariate analysis. PS and liver metastasis also remained statistically significant in multivariate analysis. Grade 3 or 4 hematologic toxicity was 20% for neutropenia, and 10% for thrombocytopenia. Other common non-hematological toxicities were peripheral neuropathy and mild liver enzyme elevation. Paclitaxel-based chemotherapy showed modest activity in SCLC patients refractory to both etoposide- and camptothecin-based chemotherapy. PS and presence of liver metastasis were predictive of survival after paclitaxel chemotherapy." @default.
• W2766871901 created "2017-11-10" @default.
• W2766871901 creator A5012153148 @default.
• W2766871901 creator A5026250495 @default.
• W2766871901 creator A5033653599 @default.
• W2766871901 creator A5044075250 @default.
• W2766871901 creator A5050098107 @default.
• W2766871901 creator A5063587278 @default.
• W2766871901 creator A5066445933 @default.
• W2766871901 creator A5078380514 @default.
• W2766871901 creator A5084847095 @default.
• W2766871901 creator A5091065629 @default.
• W2766871901 date "2017-10-01" @default.
• W2766871901 modified "2023-09-30" @default.
• W2766871901 title "Paclitaxel as third-line chemotherapy for small cell lung cancer failing both etoposide- and camptothecin-based chemotherapy" @default.
• W2766871901 cites W1565276921 @default.
• W2766871901 cites W1962294350 @default.
• W2766871901 cites W1971264126 @default.
• W2766871901 cites W1996862533 @default.
• W2766871901 cites W2000159952 @default.
• W2766871901 cites W2021907624 @default.
• W2766871901 cites W2037286635 @default.
• W2766871901 cites W2049306821 @default.
• W2766871901 cites W2056422898 @default.
• W2766871901 cites W2060171352 @default.
• W2766871901 cites W2083904374 @default.
• W2766871901 cites W2098669230 @default.
• W2766871901 cites W2103702213 @default.
• W2766871901 cites W2104575860 @default.
• W2766871901 cites W2120435735 @default.
• W2766871901 cites W2129527916 @default.
• W2766871901 cites W2139248078 @default.
• W2766871901 cites W2151177054 @default.
• W2766871901 cites W2158127925 @default.
• W2766871901 cites W2167746331 @default.
• W2766871901 cites W2168980896 @default.
• W2766871901 cites W2180665179 @default.
• W2766871901 cites W2329673293 @default.
• W2766871901 cites W2586885021 @default.
• W2766871901 doi "https://doi.org/10.1097/md.0000000000008176" @default.
• W2766871901 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5662365" @default.
• W2766871901 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29049199" @default.
• W2766871901 hasPublicationYear "2017" @default.
• W2766871901 type Work @default.
• W2766871901 sameAs 2766871901 @default.
• W2766871901 citedByCount "9" @default.
• W2766871901 countsByYear W27668719012017 @default.
• W2766871901 countsByYear W27668719012018 @default.
• W2766871901 countsByYear W27668719012019 @default.
• W2766871901 countsByYear W27668719012020 @default.
• W2766871901 countsByYear W27668719012021 @default.
• W2766871901 countsByYear W27668719012022 @default.
• W2766871901 countsByYear W27668719012023 @default.
• W2766871901 crossrefType "journal-article" @default.
• W2766871901 hasAuthorship W2766871901A5012153148 @default.
• W2766871901 hasAuthorship W2766871901A5026250495 @default.
• W2766871901 hasAuthorship W2766871901A5033653599 @default.
• W2766871901 hasAuthorship W2766871901A5044075250 @default.
• W2766871901 hasAuthorship W2766871901A5050098107 @default.
• W2766871901 hasAuthorship W2766871901A5063587278 @default.
• W2766871901 hasAuthorship W2766871901A5066445933 @default.
• W2766871901 hasAuthorship W2766871901A5078380514 @default.
• W2766871901 hasAuthorship W2766871901A5084847095 @default.
• W2766871901 hasAuthorship W2766871901A5091065629 @default.
• W2766871901 hasBestOaLocation W27668719011 @default.
• W2766871901 hasConcept C121608353 @default.
• W2766871901 hasConcept C126322002 @default.
• W2766871901 hasConcept C143998085 @default.
• W2766871901 hasConcept C178790620 @default.
• W2766871901 hasConcept C185592680 @default.
• W2766871901 hasConcept C2776256026 @default.
• W2766871901 hasConcept C2776694085 @default.
• W2766871901 hasConcept C2776907518 @default.
• W2766871901 hasConcept C2777063308 @default.
• W2766871901 hasConcept C2777292972 @default.
• W2766871901 hasConcept C2778119113 @default.
• W2766871901 hasConcept C2778336483 @default.
• W2766871901 hasConcept C2779013556 @default.
• W2766871901 hasConcept C2779682216 @default.
• W2766871901 hasConcept C2780259306 @default.
• W2766871901 hasConcept C2781209748 @default.
• W2766871901 hasConcept C526805850 @default.
• W2766871901 hasConcept C71924100 @default.
• W2766871901 hasConcept C90924648 @default.
• W2766871901 hasConceptScore W2766871901C121608353 @default.
• W2766871901 hasConceptScore W2766871901C126322002 @default.
• W2766871901 hasConceptScore W2766871901C143998085 @default.
• W2766871901 hasConceptScore W2766871901C178790620 @default.
• W2766871901 hasConceptScore W2766871901C185592680 @default.
• W2766871901 hasConceptScore W2766871901C2776256026 @default.
• W2766871901 hasConceptScore W2766871901C2776694085 @default.
• W2766871901 hasConceptScore W2766871901C2776907518 @default.
• W2766871901 hasConceptScore W2766871901C2777063308 @default.
• W2766871901 hasConceptScore W2766871901C2777292972 @default.
• W2766871901 hasConceptScore W2766871901C2778119113 @default.
• W2766871901 hasConceptScore W2766871901C2778336483 @default.
• W2766871901 hasConceptScore W2766871901C2779013556 @default.
• W2766871901 hasConceptScore W2766871901C2779682216 @default.

• next